Stay updated on Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial page.

Latest updates to the Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial page
- Check7 days agoChange DetectedA new revision entry (v3.6.6) was added to the Study Record Versions, updating the revision history to reflect the latest state of the record. The previous revision (v3.6.5) was removed from the list.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedA newer revision (v3.6.5) was added to the study's history, and the previous revision (v3.6.4) was removed from the visible history. This updates the history view to reflect the latest revision of the record.SummaryDifference0.1%

- Check42 days agoChange DetectedA new revision entry labeled v3.6.4 was added to the Study Record history, and the previous entry v3.6.3 was removed.SummaryDifference0.1%

- Check64 days agoChange DetectedAdds a new revision entry (v3.6.3) to the study record history and removes the previous revision (v3.6.2). This updates the visible version history to reflect the latest release.SummaryDifference0.1%

- Check71 days agoChange DetectedThe record history now includes a new revision entry v3.6.2, and the previous revision v3.6.0 has been removed.SummaryDifference0.1%

- Check85 days agoChange DetectedA new revision entry labeled v3.6.0 was added to the record history, representing an updated version of the study record. The previous revision v3.5.5 is now superseded in the history.SummaryDifference0.3%

Stay in the know with updates to Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial page.